Daré Bioscience (DARE) Earnings Date, Estimates & Call Transcripts $2.90 0.00 (0.00%) Closing price 05/23/2025 04:00 PM EasternExtended Trading$2.87 -0.03 (-1.17%) As of 05/23/2025 07:09 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Daré Bioscience Earnings Summary Daré Bioscience announced Q1 2025 earnings on May 13, 2025, reporting an EPS of -$0.50, which beat the consensus estimate of -$0.63 by $0.13. Quarterly revenue was reported to be $0.03 million, below analysts' expectations of $0.60 million. With a trailing EPS of -$0.17, Daré Bioscience's earnings are expected to decrease next year, from ($0.49) to ($1.90) per share. Upcoming Q2 Earnings DateAug. 11After Market ClosesEstimatedConsensus EPS (May. 13) -$0.63 Actual EPS (May. 13) -$0.50 Beat By $0.13 Actual Revenue (May. 13) $0.03MQ1 2025 Earnings ResourcesQ1 2025 Earnings ReportConference Call Transcript & Audio Press Release (8-K) Quarterly Report (10-Q)DARE Upcoming EarningsDaré Bioscience's next earnings date is estimated for Monday, August 11, 2025, based on past reporting schedules. Powered by Get Daré Bioscience Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Daré Bioscience and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataDARE Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.DARE Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Daré Bioscience Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20252-$0.68-$0.57-$0.63Q2 20252-$0.48-$0.23-$0.36Q3 20252-$0.48-$0.45-$0.47Q4 20252-$0.57-$0.21-$0.39 Daré Bioscience Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 8/11/2025(Estimated)--------5/13/2025Q1 2025-$0.63-$0.50+$0.13-$0.50$0.60M$0.03M3/31/2025Q4 2024-$0.66-$0.64+$0.02-$0.64$1.00M-$0.06M8/12/2024Q2 2024-$0.57$1.52+$2.09$1.52$0.60M$0.02M5/14/2024Q1 2024-$0.72-$0.84 -$0.12-$0.07$0.52M$0.01M3/28/2024Q4 2023-$1.44-$0.72+$0.72-$0.06$2.17M$1.81M11/9/2023Q3 2023-$1.20-$1.08+$0.12-$0.09$1.20M$1.00M8/10/2023Q2 2023-$1.20-$1.20--$0.10-- Daré Bioscience Earnings - Frequently Asked Questions When is Daré Bioscience's earnings date? Daré Bioscience has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, August 11th, 2025 based off last year's report dates. Learn more on DARE's earnings history. Did Daré Bioscience beat their earnings estimates last quarter? In the previous quarter, Daré Bioscience (NASDAQ:DARE) reported ($0.50) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.63) by $0.13. Learn more on analysts' earnings estimate vs. DARE's actual earnings. How can I listen to Daré Bioscience's earnings conference call? The conference call for Daré Bioscience's latest earnings report can be listened to online. Listen to Conference Call How can I read Daré Bioscience's conference call transcript? The conference call transcript for Daré Bioscience's latest earnings report can be read online. Read Transcript How much revenue does Daré Bioscience generate each year? Daré Bioscience (NASDAQ:DARE) has a recorded annual revenue of $25,909.00. How much profit does Daré Bioscience generate each year? Daré Bioscience (NASDAQ:DARE) has a recorded net income of -$30.16 million. DARE has generated -$0.17 earnings per share over the last four quarters. What is Daré Bioscience's EPS forecast for next year? Daré Bioscience's earnings are expected to decrease from ($0.49) per share to ($1.90) per share in the next year. More Earnings Resources from MarketBeat Related Companies VTYX Earnings Results VIRI Earnings Results MGNX Earnings Results SAVA Earnings Results COYA Earnings Results GNLX Earnings Results OPTN Earnings Results CCCC Earnings Results HLVX Earnings Results CRBU Earnings Results Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Booz Allen Hamilton Earnings: 3 Bullish Signals for BAH StockAdvance Auto Parts Jumps on Surprise Earnings BeatAlibaba's Earnings Just Changed Everything for the StockCisco Stock Eyes New Highs in 2025 on AI, Earnings, UpgradesSymbotic Gets Big Earnings Lift: Is the Stock Investable Again?D-Wave Pushes Back on Short Seller Case With Strong EarningsAppLovin Surges on Earnings: What's Next for This Tech Standout? This page (NASDAQ:DARE) was last updated on 5/24/2025 by MarketBeat.com Staff From Our PartnersTrump Predicts Dollar DownfallREAD THIS VERY CAREFULLY: If you have $100,000 or more saved for retirement, this may make you VERY angry... ...Augusta Precious Metals | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredWatch This Robotics Demo Before July 23rdJeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%... ...Brownstone Research | Sponsored$19 for a FULL YEAR of stock picks?!Invest in Musk's AI Play With Just $100 You don't need deep pockets to ride the next wave of AI wealth. ...Behind the Markets | SponsoredBanks aren’t ready for this altcoin—are you?While everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly po...Crypto 101 Media | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | SponsoredAfter Monday, price goes up 600% (hurry)Right now, for a limited time… You can get up to 52 Money Monday trades for just $7! Thanks to Wall Street’...Timothy Sykes | SponsoredMemorial Day Sale! 82% Off Disruptors and Dominators!Jensen Huang recently gave the keynote speech at the Consumer Electronics Show in Las Vegas. When the Nvidi...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Daré Bioscience, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Daré Bioscience With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.